Email alerts
Advanced Search
  • Jul 25, 2014
    Covidien Reports Third-Quarter Fiscal 2014 Results
    Net sales up 4%; Medical Devices sales up 5%

    DUBLIN, Ireland--(BUSINESS WIRE)--Jul. 25, 2014-- Covidien plc (NYSE: COV) today announced financial results for the third quarter of fiscal 2014. Third-quarter net sales of $2.69 billion...

  • Jul 21, 2014
    Covidien Announces Leadership Appointment

    DUBLIN, Ireland--(BUSINESS WIRE)--Jul. 22, 2014-- Covidien plc (NYSE: COV) today announced that Bryan Hanson, who currently serves as group president, Medical Devices & U.S., will be elevated to...

  • Jul 17, 2014
    HeartWare Schedules Second Quarter Conference Call And Webcast

    HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended June 30, 2014, at 8:00 a.m. U.S. Eastern Daylight Time on...

  • Jul 16, 2014
    Covidien Makes Liver Tumor Ablation More Predictable
    Emprint™ Ablation System enables more certainty regardless of target location or tissue type

    DUBLIN, Ireland--(BUSINESS WIRE)--Jul. 16, 2014-- Overcoming a significant roadblock to predictable ablation of soft tissue, Covidien plc (NYSE:COV) has unveiled an advanced ablation system that...

  • Jul 14, 2014
    Announcement under Irish Takeover Rules Relevant Securities in Issue – July 14, 2014

    DUBLIN, Ireland--(BUSINESS WIRE)--Jul. 14, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...

Show 5102550100 per page